EntryPoint Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
+9,541
| New | +$206K | 0.1% | 472 |
|
|
2025
Q1 | – | Sell |
-26,022
| Closed | -$478K | – | 655 |
|
|
2024
Q4 | $478K | Buy |
26,022
+15,052
| +137% | +$276K | 0.2% | 122 |
|
|
2024
Q3 | $169K | Buy |
10,970
+3,544
| +48% | +$54.5K | 0.1% | 503 |
|
|
2024
Q2 | $121K | Buy |
7,426
+2,711
| +57% | +$44.1K | 0.18% | 228 |
|
|
2024
Q1 | $87.2K | Sell |
4,715
-994
| -17% | -$18.4K | 0.08% | 498 |
|
|
2023
Q4 | $179K | Buy |
+5,709
| New | +$179K | 0.17% | 122 |
|